Cargando…

Monkeypox vaccines and vaccination strategies: Current knowledge and advances. An update – Correspondence

Detalles Bibliográficos
Autores principales:	Chakraborty, Sandip, Mohapatra, Ranjan K., Chandran, Deepak, Alagawany, Mahmoud, Sv, Praveen, Islam, Md Aminul, Chakraborty, Chiranjib, Dhama, Kuldeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533893/ https://www.ncbi.nlm.nih.gov/pubmed/36049620 http://dx.doi.org/10.1016/j.ijsu.2022.106869

Ejemplares similares

Langya virus, a newly identified Henipavirus in China - Zoonotic pathogen causing febrile illness in humans, and its health concerns: Current knowledge and counteracting strategies – Correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Recent re-emergence of Marburg virus disease in an African country Ghana after Guinea amid the ongoing COVID-19 pandemic: Another global threat? Current knowledge and strategies to tackle this highly deadly disease having feasible pandemic potential
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Monkeypox in South-East Asia: Is an alarming bell for this region? – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

A call for a novel and next-generation vaccine against monkeypox disease
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Organ-on-chip: a new paradigm for clinical trials – correspondence
por: Chopra, Hitesh, et al.
Publicado: (2023)

Monkeypox virus vaccine evolution and global preparedness for vaccination
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

Advances in artificial intelligence based diagnosis and treatment of liver diseases – Correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Emerging cases of acute hepatitis of unknown origin in children amid the ongoing COVID-19 pandemic: Needs attention – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Artificial intelligence (AI) is paving the way for a critical role in drug discovery, drug design, and studying drug–drug interactions – correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Monkeypox plays a similar role like SARS-CoV-2; intensive animal screening is crucial after the first human-to-dog transmission report – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Advances in artificial intelligence (AI)-based diagnosis in clinical practice—correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Recent first report of human-to-dog transmission of Monkeypox virus emphasizes an urgent need of enhancing surveillance and strengthen further explorative research to reveal its real magnitude of reverse zoonosis from other animals including pets as like that happened with SARS-CoV-2 / COVID-19 pandemic – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties – an alarming global threat of a surge in COVID-19 cases again?
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Recently emerged omicron subvariant BF.7 and its R346T mutation in the RBD region reveal increased transmissibility and higher resistance to neutralization antibodies: need to understand more under the current scenario of rising cases in China and fears of driving a new wave of the COVID-19 pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants
por: Kaiwan, Oroshay, et al.
Publicado: (2023)

Recent outbreaks of hantavirus-a very lethal and zoonotic virus – An update and counteracting strategies
por: Sah, Ranjit, et al.
Publicado: (2022)

The D614G mutation helps to increase the transmissibility and reduce the virulence of SARS-CoV-2 variants through natural selection
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

The re-emergence of measles is posing an imminent global threat owing to decline in its vaccination rates amid COVID-19 pandemic: a special focus on recent outbreak in India – a call for massive vaccination drive to be enhanced at global level
por: Suvvari, Tarun K., et al.
Publicado: (2023)

Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023)

Current scenario of recently rising up cases of invasive group A streptococcal (iGAS) infections in younger children in many European nations: clinical management and prospective counteracting measures – an update
por: Chopra, Hitesh, et al.
Publicado: (2023)

Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Countering hepatitis E infection in South Sudan in the backdrop of recent outbreak
por: Chakraborty, Sandip, et al.
Publicado: (2023)

Monkeypox lineages amid the ongoing COVID-19 pandemic: A global public health concern – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
por: Islam, Md. Aminul, et al.
Publicado: (2023)

Environmental Health Risks After the 2023 Turkey-Syria Earthquake and Salient Mitigating Strategies: A Critical Appraisal
por: Ahmed, Sirwan Khalid, et al.
Publicado: (2023)

Cases of BA.2.75 and recent BA.2.75.2 subvariant of Omicron are increasing in India: Is it alarming at the global level?
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Monkeypox clinical symptoms, pathology, and advances in management and treatment options: an update
por: Ahmed, Sirwan K., et al.
Publicado: (2023)

MERS-CoV recently re-emerged in Qatar, Saudi Arabia, its feasible global health risks amid FIFA world cup 2022 and salient counteracting strategies – an update
por: Chopra, Hitesh, et al.
Publicado: (2023)

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Dengue virus and its recent outbreaks: current scenario and counteracting strategies
por: Sah, Ranjit, et al.
Publicado: (2023)

BF.7 Omicron subvariant (BA.5.2.1.7) posing fears of a rise in COVID-19 cases again: a critical appraisal and salient counteracting strategies
por: Dhama, Kuldeep, et al.
Publicado: (2023)

Artificial intelligence–enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: A travelers' prospective
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4f1j3s3epff7qgitaavgl2vs0k